Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study

CompletedOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

September 12, 2022

Study Completion Date

September 12, 2022

Conditions
Critical Limb IschemiaPeripheral Artery Disease
Trial Locations (25)

20782

MedStar D.C., Hyattsville

23298

VCU, Virginia Commonwealth University Health System, Richmond

27518

APCNC (Wake Med), Cary

27834

East Carolina University (ECU, Vidant Medical), Greenville

28401

Coastal Carolina Surgical, Wilmington

29407

Coastal Vascular and Vein Center, Charleston

29615

Prisma Health, Greenville

29621

Anderson Heart and Vascular, Anderson

32605

The Cardiac and Vascular Institute, Gainesville

44106

University Hospitals Cleveland Medical Center, Cleveland

48236

Ascension St. John Detroit, Detroit

50266

Unity Point Health, Des Moines

64111

St. Lukes Mid America, Kansas City

70065

Ochsner Medical Center, Kenner

77030

Baylor College of Medicine, Houston

78229

UT-San Antonio, San Antonio

78705

Seton Heart Institute, Austin

78727

Austin Radiological Association, Austin

80205

Denver Veterans Affairs Medical Center, Denver

90057

LA Foot & Ankle Clinic - St. Vincent's Hospital, Los Angeles

90501

Harbor- UCLA Medical Center, Torrance

02114

Massachusetts General Hospital, Boston

02118

Boston Medical Center, Boston

03766

Dartmouth-Hitchcock Medical Center, Lebanon

00716

San Lucas Hospital, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LimFlow, Inc.

INDUSTRY